Advantage of recombinant von Willebrand factor for peri-operative management in paediatric acquired von Willebrand syndrome

被引：6
|
作者：
Weyand, A. C. [1 ]
Jesudas, R. [2 ]
Pipe, S. W. [1 ,3 ]
机构：
[1] Univ Michigan, Dept Paediat & Communicable Dis, Ann Arbor, MI 48109 USA
[2] Bleeding & Clotting Disorders Inst, Peoria, IL USA
[3] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
来源：
HAEMOPHILIA | 2018年 / 24卷 / 03期
关键词：
FACTOR-VIII; DISEASE; RISK;
D O I：
10.1111/hae.13436
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E120 / E121
页数：2
相关论文
共 50 条
  • [41] Acquired von Willebrand syndrome and acquired haemophilia
    Sauguet, Pauline
    Theron, Alexandre
    HEMATOLOGIE, 2015, 21 (05): : 295 - 302
  • [42] Treatment of the acquired von Willebrand syndrome
    Budde, Ulrich
    Scheppenheim, Sonja
    Dittmer, Rita
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (06) : 799 - 818
  • [43] Acquired von Willebrand syndrome (AVWS)
    Federici, A. B.
    HAEMOPHILIA, 2008, 14 : 1 - 1
  • [44] von Willebrand factor Ristocetin co-factor activity to von Willebrand factor antigen level ratio for diagnosis of acquired von Willebrand syndrome caused by aortic stenosis
    Okubo, Noriyuki
    Sugawara, Shingo
    Fujiwara, Tohru
    Sakatsume, Ko
    Doman, Tsuyoshi
    Yamashita, Mihoko
    Goto, Kota
    Tateishi, Masaki
    Suzuki, Misako
    Shirakawa, Ryutaro
    Eura, Yuka
    Kokame, Koichi
    Hayakawa, Masaki
    Matsumoto, Masanori
    Kawate, Yasunori
    Miura, Mizuki
    Takiguchi, Hiroshi
    Soga, Yoshimitsu
    Shirai, Shinichi
    Ando, Kenji
    Arai, Yoshio
    Nakayoshi, Takaharu
    Fukumoto, Yoshihiro
    Takahama, Hiroyuki
    Yasuda, Satoshi
    Tamura, Toshihiro
    Watanabe, Shin
    Kimura, Takeshi
    Yaoita, Nobuhiro
    Shimokawa, Hiroaki
    Saiki, Yoshikatsu
    Kaikita, Koichi
    Tsujita, Kenichi
    Yoshii, Shinji
    Nakase, Hiroshi
    Fujimaki, Shin-ichi
    Horiuchi, Hisanori
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (01)
  • [45] von Willebrand disease and von Willebrand factor
    Sadler, Brooke
    Castaman, Giancarlo
    O'Donnell, James S.
    HAEMOPHILIA, 2022, 28 : 11 - 17
  • [46] Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient
    Hoepting, Matthias
    Budde, Ulrich
    Tiede, Andreas
    Grube, Matthias
    Hahn, Joachim
    Herr, Wolfgang
    Heimerl, Susanne
    Hart, Christina
    ACTA HAEMATOLOGICA, 2022, 145 (04) : 454 - 457
  • [47] von Willebrand Factor and von Willebrand Disease
    王兆钺
    血栓与止血学, 2005, (04) : 147 - 149
  • [48] Preclinical evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
    Schwarz, HP
    Dorner, F
    Mitterer, A
    Mundt, W
    Schlokat, U
    Pichler, L
    Turecek, PL
    WIENER KLINISCHE WOCHENSCHRIFT, 1999, 111 (05) : 181 - 191
  • [49] Successful Management of Pregnancy with Sever Von Willebrand Disease in a Jehovah's Witness with Recombinant Von Willebrand Factor
    Kazi, Sajida
    Malinowski, Ann Kinga
    Whitehead, Clare
    Kuo, Kevin H. M.
    Harrington, Lynda
    Watts, Nancy
    Wang, Chen
    Shehata, Nadine
    BLOOD, 2018, 132
  • [50] Use of Recombinant Factor VIIa in Inherited and Acquired von Willebrand Disease
    Sucker, Christoph
    Scharf, Ruediger E.
    Zotz, Rainer B.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (01) : 27 - 31
12345